Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-02-13

Clinical Trial Update: Withdrawal of Steroids, Cyclosporine A Dose Reduction and Switch to Mycophenolatmofetile After Heart Transplantation [NA]

View source ↗

Summary

The trial update notes withdrawal of steroids, reduction of cyclosporine A dose, and switch to mycophenolate mofetil after heart transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyclosporine A (cyclosporine)
  • MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
  • steroids

Snippet

Sponsor: Hannover Medical School | Conditions: Heart Transplantation | NA | Status: COMPLETED